Paper26933263
Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
Wang SL and 2 others. Can Vet J, 2016. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. Papers, record 26933263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26933263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Dog Diseases | Major topic |
| Doxorubicin | Major topic |
| Lymphoma | Major topic |
| Mitoxantrone | Major topic |
| Animals | |
| Cyclophosphamide | |
| Dogs | |
| Female | |
| Male | |
| Prednisone | |
| Prospective Studies | |
| Vincristine |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12465768 | Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. | J Vet Intern Med | 2002 | https://conductscience.org/library/papers/12465768 | PubMed |
| 2 | 19379294 | Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. | Vet Comp Oncol | 2004 | https://conductscience.org/library/papers/19379294 | PubMed |
| 3 | 7744644 | Prognostic factors for treatment of malignant lymphoma in dogs. | J Am Vet Med Assoc | 1994 | https://conductscience.org/library/papers/7744644 | PubMed |
| 4 | 8077132 | Evaluation of mitoxantrone for the treatment of lymphoma in dogs. | J Am Vet Med Assoc | 1994 | https://conductscience.org/library/papers/8077132 | PubMed |
| 5 | 1277204 | Delayed and progressive myocardial lesions after adriamycin administration in the rabbit. | Cancer Res | 1976 | https://conductscience.org/library/papers/1277204 | PubMed |
| 6 | 3333887 | Canine lymphoma: clinical considerations. | Semin Vet Med Surg Small Anim | 1986 | https://conductscience.org/library/papers/3333887 | PubMed |
| 7 | 7879983 | Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs. | Am J Vet Res | 1994 | https://conductscience.org/library/papers/7879983 | PubMed |
| 8 | 20230579 | Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document. | Vet Comp Oncol | 2010 | https://conductscience.org/library/papers/20230579 | PubMed |
| 9 | 5538360 | The epidemiology of canine leukemia and lymphoma. | Bibl Haematol | 1970 | https://conductscience.org/library/papers/5538360 | PubMed |
| 10 | 11467592 | Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. | J Vet Intern Med | 2001 | https://conductscience.org/library/papers/11467592 | PubMed |
| 11 | 8823340 | Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8823340 | PubMed |
| 12 | 20445802 | Hormonal and sex impact on the epidemiology of canine lymphoma. | J Cancer Epidemiol | 2009 | https://conductscience.org/library/papers/20445802 | PubMed |
| 13 | 7083217 | Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/7083217 | PubMed |
| 14 | 20230577 | Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma. | Vet Comp Oncol | 2010 | https://conductscience.org/library/papers/20230577 | PubMed |
| 15 | 18289305 | Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. | J Vet Intern Med | 2008 | https://conductscience.org/library/papers/18289305 | PubMed |
| 16 | 1588546 | Doxorubicin-induced cardiotoxicosis. Clinical features in 32 dogs. | J Vet Intern Med | 1992 | https://conductscience.org/library/papers/1588546 | PubMed |
| 17 | 14197830 | GENETIC ASPECTS OF CARDIOVASCULAR DISEASES IN ANIMALS. | Circulation | 1964 | https://conductscience.org/library/papers/14197830 | PubMed |
| 18 | 657163 | Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/657163 | PubMed |
| 19 | 2568172 | Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. | Cancer Res | 1989 | https://conductscience.org/library/papers/2568172 | PubMed |
| 20 | 20492493 | Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: a proof-of-concept pilot study. | J Vet Intern Med | 2010 | https://conductscience.org/library/papers/20492493 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40443182 | Comparison of outcomes in feline intermediate- to large-cell lymphoma treated with CMOP (cyclophosphamide, mitoxantrone, vincristine and prednisolone) instead of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone). | J Feline Med Surg | 2025 | https://conductscience.org/library/papers/40443182 | PubMed |
| 39902544 | Two GnRH-mitoxantrone Conjugates, Con-3 and Con-7, Target Endometrial Cancer Cells | Curr Mol Pharmacol | 2024 | https://conductscience.org/library/papers/39902544 | PubMed |
| 39274973 | Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells. | Molecules | 2024 | https://conductscience.org/library/papers/39274973 | PubMed |
| 38647264 | Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma. | J Feline Med Surg | 2024 | https://conductscience.org/library/papers/38647264 | PubMed |
| 37249647 | Fusion protein and hemagglutinin of canine distemper virus co-induce apoptosis in canine mammary tumor cells. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37249647 | PubMed |
| 37235425 | Review of Canine Lymphoma Treated with Chemotherapy-Outcomes and Prognostic Factors. | Vet Sci | 2023 | https://conductscience.org/library/papers/37235425 | PubMed |
| 35307756 | Interceptor potential of C60 fullerene aqueous solution: a comparative analysis using the example of the antitumor antibiotic mitoxantrone. | Eur Biophys J | 2022 | https://conductscience.org/library/papers/35307756 | PubMed |
| 34825413 | Toxicity, outcome, and management of anthracycline overdoses in 16 dogs. | J Vet Intern Med | 2022 | https://conductscience.org/library/papers/34825413 | PubMed |
| 33898277 | Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines. | Open Vet J | 2021 | https://conductscience.org/library/papers/33898277 | PubMed |
| 31812160 | Antiviral activity of mitoxantrone dihydrochloride against human herpes simplex virus mediated by suppression of the viral immediate early genes. | BMC Microbiol | 2019 | https://conductscience.org/library/papers/31812160 | PubMed |
| 30373251 | Oncolytic Viruses for Canine Cancer Treatment. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30373251 | PubMed |
| 30209630 | Influence of Carbon Nanotubes and Its Derivatives on Tumor Cells In Vitro and Biochemical Parameters, Cellular Blood Composition In Vivo. | Nanoscale Res Lett | 2018 | https://conductscience.org/library/papers/30209630 | PubMed |
| 28272340 | Factors Which Influence Owners When Deciding to Use Chemotherapy in Terminally Ill Pets. | Animals (Basel) | 2017 | https://conductscience.org/library/papers/28272340 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26933263
GET https://conductscience.org/api/papers/v1/26933263/references?page=2